| Advantages | When cultured long-term under defined conditions, these organoids recapitulate key features of in vivo tumor physiology, making them valuable tools for translational research and therapeutic development. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Uterine |
| Disease | Cancer |
| Format | Frozen |
| Organoid Characterization | They retain the morphological complexity, hormone receptor status, and genetic aberrations of the original tumor, including those characteristic of type I and type II endometrial cancers. |
| Applications | Human uterine corpus cancer organoids are 3D models derived from uterine cancer tissues, primarily endometrial carcinoma. They recapitulate key features of the uterine corpus, including tumor heterogeneity, epithelial architecture, and molecular characteristics of the original tissue. These organoids provide an advanced platform for studying uterine cancer progression, drug response, and therapeutic resistance. Applications in preclinical drug testing, targeted therapy development, and personalized medicine enable researchers to better understand molecular drivers of endometrial cancer and improve treatment outcomes. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.